-
Cuba scrambles to restore power as Trump threatens takeover
-
War fuels fears of new oil crisis
-
Kerr 'frustrated' at six-figure sum owed to him by Johnson's failed Grand Slam Track
-
Senior US counterterrorism official resigns to protest Iran war
-
In shadow of Iran war, Gazans prepare for Eid
-
Oil prices climb as fresh strikes target infrastructure
-
Southern Lebanon paramedics risk deadly Israeli strikes to do their work
-
Len Deighton, spy novelist who created the anti-Bond
-
Barca Flick's 'last job' but not yet certain on renewal
-
Belgian diplomat ordered to stand trial over 1961 Congo leader murder
-
Pope says idea England 'weren't fussed' about the Ashes was tough to take
-
War threatens Gulf's dugongs, turtles and birds
-
Germany targets oil firms to prevent wartime price gouging
-
Chelsea striker Kerr sends Australia into Asian Cup final
-
'East meets West': KPop Demon Hunters brings global fans to Seoul's sites
-
EU to help reopen blocked oil pipeline in Ukraine
-
Thai eSports players sentenced over SEA Games cheating scandal
-
Nigeria suicide bombings kill 23, wound more than 100
-
Iran's Larijani, the man whose power grew during Mideast war
-
Israel says killed Iran national security chief Larijani
-
Millions of Indonesians in Eid travel exodus
-
Israel strikes Beirut suburbs as displacement shelters overflow
-
Hard-hitting Conway steers New Zealand to victory over South Africa
-
During Ramadan, Senegal's Baye Fall community lives to serve
-
Afghan govt says 'around 400' killed in Pakistani strike on Kabul rehab clinic
-
Russian ballet banned for 'gay propaganda' gets new life in Berlin
-
Malaysia hit with 3-0 forfeits to send Vietnam to Asian Cup
-
Rescue workers comb ruins of Kabul drug clinic after Pakistan strike
-
'Many dead': Wounded survivor escaped Kabul clinic strike
-
Belgian court decides on holding trial over 1961 Congo leader murder
-
Kabul drug rehab clinic in ruins after Pakistan strikes on Afghanistan
-
Israel strikes Tehran, Beirut as Iraq pulled deeper into Mideast war
-
Georgia ready for rugby elite despite rare Portugal defeat
-
Doncic leads Lakers to sixth straight win, Spurs sink Clippers
-
Iran 'negotiating' with FIFA over moving World Cup games to Mexico: embassy
-
Gavaskar condemns Indian-owned franchise for signing Pakistan bowler
-
Cash handouts, fare hikes as Philippines battles soaring fuel costs
-
Alleged Bondi Beach killer's mother received death threats, court told
-
Venezuela end Italy fairytale to reach World Baseball Classic final
-
Sweden's prisons prepare to house young teens
-
Indonesia weighs response to price pressures from Middle East war
-
In Hollywood, AI's no match for creativity, say top executives
-
Sao Paulo AI policing nabs criminals, and a few innocents
-
Trump faces coalition of the unwilling on Iran
-
Nvidia chief expects revenue of $1 trillion through 2027
-
Nvidia making AI module for outer space
-
Migrant workers bear brunt of Iran attacks in Gulf
-
Nearly Three-Quarters of Americans Feel Optimistic About Their Financial Future Even Amid Economic Uncertainty, New Survey Finds
-
Allied Universal Granted Patent for Canine Air Cargo Screening Technology
-
Sauce Labs CEO, Prince Kohli, Says $1 Trillion Software Quality Industry Has Been "Building Wrong" for 20 Years
Path Fertility Releases its SpermQT Facts Sheet
SALT LAKE CITY, UT / ACCESS Newswire / March 17, 2026 / Path FertilityTM, an epigenetics-driven fertility technology company, today unveiled its SpermQTTM Facts Sheet, a copy of which is embedded below within this news release.
BEGINNING OF Path Fertility's SpermQT Facts Sheet.
SpermQTIntroduction
SpermQT is a clinically validated epigenetic sperm quality test from Path Fertility designed to help answer a practical question in fertility care: Are sperm likely to function well enough to support pregnancy, even when Semen Analysis results look "Normal"?

Traditional Semen Analysis testing is still the "Standard of Care" in fertility circles. It measures sperm count, movement, and shape. Conversely, SpermQT adds an additional layer of insight by analyzing sperm DNA methylation patterns associated with sperm function, i.e., the presence of certain DNA abnormalities in sperm.
The Problem Addressed
Many couples spend months making decisions based on incomplete information about male fertility. Common patterns include:
Semen Analysis comes back "Normal," but pregnancy still does not happen;
A couple is labeled "unexplained infertility" and treatment escalates without more clear male-factor insights;
Couples repeat time-consuming cycles and procedures without better diagnostics to guide next steps; and
Decisions around intrauterine insemination (IUI) are made with limited ability to predict success.

PHOTO CAPTION: SpermQT overview page from Path Fertility. March 2026
Couples that Can Benefit from SpermQT
SpermQT is especially relevant for:
Couples exploring fertility options that want better clarity earlier in the process;
Couples diagnosed with unexplained infertility, including cases with "Normal" Semen Analysis results;
Couples considering intrauterine insemination (IUI), a procedure where prepared sperm is placed into the uterus during ovulation;
Couples that need clearer guidance on what to do after experiencing failed IUIs; and
Healthcare professionals and providers seeking a more complete initial male fertility workup beyond Semen Analysis alone.
What SpermQT Measures
SpermQT analyzes epigenetic patterns (DNA methylation) in sperm. These patterns are associated with the biological steps sperm must complete to support pregnancy, often described as:
Find an egg,
Bind to an egg,
Penetrate an egg, and
Fertilize an egg.
SpermQT evaluates DNA methylation dysregulation across 1,200+ genes linked to sperm function.
VIDEO CAPTION - Path Fertility's "SpermQT: A NEW KIND OF SPERM TEST" video, also found on YouTube here: https://www.youtube.com/watch?v=EHvFUEBctTs.
SpermQT Test Results
SpermQT results are delivered in three categories:
Excellent
Normal
Abnormal
Key Takeaways, in Plain English
SpermQT is designed to add functional insight that Semen Analysis does not measure.
An Abnormal SpermQT result can provide a signal that sperm function may be contributing to infertility, even when Semen Analysis results are listed as "Normal."
SpermQT is positioned as an early, complementary test to help guide decision-making around IUI planning and next-step conversations.
Key Clinical Insights
A review of the clinical data shows that SpermQT is positioned to help in three specific ways -
Prediction for IUI planning:
Published clinical data reports statistically significant differences in pregnancy and live birth outcomes across SpermQT result tiers in IUI settings.Identifying "hidden" male-factor risk missed by Semen Analysis tests:
Path Fertility states that many Abnormal SpermQT results occur in men whose semen parameters appear normal on Semen Analysis, including the commonly cited "4 out of 5" framing.IVF with ICSI context:
Published findings suggest that in certain datasets, IVF with ICSI may reduce or overcome outcome differences associated with Abnormal SpermQT results.
In Vitro Fertilization (IVF): eggs are retrieved and fertilized in a lab, then an embryo is transferred to the uterus.
Conversely, Intracytoplasmic Sperm Injection (ICSI): a technique used with IVF where a single sperm is injected directly into an egg.
When to Use SpermQT (Practical Guidance)
Consider SpermQT when:
Semen Analysis results are Normal but pregnancy is not happening;
IUIs have failed and you need more insight into whether to continue IUI or move forward;
Clearer guidance is needed before investing time and money into IUI cycles; and
A more complete male-factor picture is desired earlier in the fertility workup.
{NOTE: SpermQT is not a replacement for Semen Analysis. It is intended to complement the traditional "Standard of Care" available via traditional Semen Analysis with functional insights.}
How It Works
Sample collected, followed by
→ Lab analysis of sperm DNA methylation patterns
→ SpermQT tier result (Excellent, Normal, Abnormal)
→ Patient and provider use results to inform next steps, including IUI planning and whether IVF options should be discussed
SpermQT Ordering and Pricing
SpermQT is physician ordered, with samples collected at home or in a clinic, with results typically available within 2 weeks.
Cash-pay Price: $385
With Semen Analysis bundle: $499
{NOTE: Many organizations cover the cost of SpermQT tests through their insurance/benefits programs. Couples faced with infertility challenges are encouraged to check with their insurance providers and/or Human Resources representative(s) to learn more.}

PHOTO CAPTION: The SpermQT at-home test from Path Fertility. March 2026
Contacts
Web: PathFertility.com
Provider support: Via Path Fertility
PR/Media Contact: David Politis, [email protected], +1-801-556-8184
END OF Path Fertility's SpermQT Facts Sheet AND COMPLETION OF THE NEWS RELEASE BELOW
About Path Fertility and SpermQT
Path Fertility is focused on raising the "Standard of Care" in male fertility by providing deeper insight into sperm quality and function. As such, SpermQT is a sperm quality test based on epigenetic DNA-markers and is designed to complement Semen Analysis by adding new information related to sperm function.
Path Fertility, SpermQT, and the Path Fertility logos are trademarks of Inherent Biosciences, Inc. All other trademarks are property of their respective owners.
# # #
Media Contact: David Politis, [email protected], +1-801-556-8184
SOURCE: Path Fertility
View the original press release on ACCESS Newswire
O.Norris--AMWN